Twist Bioscience (TWST) reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier.
Analysts polled by FactSet expected a loss of $0.68.
Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier.
Analysts surveyed by FactSet expected $87 million.
The company said it expects fiscal Q2 revenue of $91 million to $93 million.
Analysts polled by FactSet expect $90.9 million.
For fiscal 2025, Twist Bioscience raised its revenue guidance to $372 million to $379 million, compared with its previous guidance range of $367 million to $377 million.
Analysts polled by FactSet expect 373.3 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。